ReviewJournal of clinical neurophysiology : official publication of the American Electroencephalographic Society2026
Pathophysiology and Prognostic Significance of Myoclonus in Hypoxic-Ischemic Encephalopathy.
Review in Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
summaryCerebral hypoxia due to cardiac arrest is frequently complicated by myoclonus manifesting hours to days after the return of spontaneous circulation. However, myoclonus per se-without further characterization-lacks sufficient biological specificity and does not allow for reliable prognostic interpretation. Accumulating evidence underscores the critical role of EEG monitoring in the assessment of postanoxic patients, particularly with regard to background continuity and the presence of status epilepticus, as defined by the American Clinical Neurophysiology Society. These parameters have emerged as key determinants in prognostication. A structured research framework for the classification of postanoxic myoclonus has been proposed to mitigate the risk of false-positive predictions of poor neurological outcome and to prevent unwarranted withdrawal of life-sustaining therapy in selected patient subgroups. These subgroups are defined by continuous, nearly continuous, or discontinuous EEG background activity, particularly in the absence of concomitant status epilepticus. This framework constitutes a robust foundation for the systematic acquisition of relevant clinical and paraclinical data. In addition, a standardized communication tool may facilitate precise information exchange among physicians and efficient interprofessional patient management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.